Paul Gurbel, MD
Enriched profileDirector, Sinai Center for Thrombosis Research and Drug Development · Sinai Hospital of Baltimore
Paul Gurbel is Director, Sinai Center for Thrombosis Research and Drug Development at Sinai Hospital of Baltimore. OpenAlex indexes 828 publications with 36,898 citations (h-index 81); ClinicalTrials.gov lists 19 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Paul A. Gurbel, MD, is Director, Sinai Center for Thrombosis Research and Drug Development at Sinai Hospital of Baltimore / LifeBridge Health. The public record shows 828 publications with 36,898 citations (h-index 81), centered on Coronary Artery Disease / ACS. It also documents an investigator role on 19 registered clinical trials, industry payments reported by 42 companies.
- Most recent indexed publication: 2026 · Arteriosclerosis, thrombosis, and vascular biology
- Top research focus: Coronary Artery Disease / ACS
- 19 registered trials on ClinicalTrials.gov
- Open Payments reporting from 42 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:
- In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme
Sponsor: LifeBridge Health
- Assessment of Platelet Function in Patients Undergoing Open Heart Surgery
Sponsor: LifeBridge Health
- The Evaluation of Hemostasis in Hospitalized COVID-19 Patients
Sponsor: LifeBridge Health
Industry payments
Updated 27 Aug 2026
42 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Kestra Medical Technology Services, Inc.Program year20257 payments
- Novo Nordisk IncProgram year202511 payments
- Abbott LaboratoriesProgram year20254 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89.8%Statin27.9%Atorvastatin Calcium56%Rosuvastatin Calcium37%Pravastatin Sodium5%Simvastatin2%Part D<11 patientsBeta blocker17.9%Metoprolol Succinate55%Carvedilol19%Metoprolol Tartrate16%Atenolol5%Nebivolol Hcl3%Labetalol Hcl3%Part D<11 patientsBlood & clotting
10.2%Factor Xa inhibitor5.9%Eliquis77%Xarelto23%Part D≥31 patientsP2Y12 inhibitor4.3%Clopidogrel63%Brilinta37%Part D≥24 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- PPI-Clopidogrel Interaction: Can Claims Data Settle the Debate?
Arteriosclerosis, thrombosis, and vascular biology
Editorial2026 - New interest in fibrinogen as an ischemic risk factor.
Journal of thrombosis and thrombolysis
Article2024 - Identifying the vulnerable patient: pericoronary Adipose tissue attenuation on computed tomography.
Journal of thrombosis and thrombolysis
Editorial2024 - Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
European heart journal
Article2024
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/paul-gurbel-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/paul-gurbel-238143287
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Paul-Gurbel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/CBSBaltimore/videos/ask-a-doc-heart-health/1293465537694421
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.lifebridgehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
- Board Certified
Cardiovascular Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.lifebridgehealth.org ↗ - Board Certified
Interventional Cardiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.lifebridgehealth.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thedailyrecord.com ↗
- Editorial Board Member
Journal of the American College of Cardiology (JACC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.lifebridgehealth.org ↗ - Editorial Board Member
Journal of the Royal Society of Medicine (Cardiovascular Disease)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.lifebridgehealth.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thedailyrecord.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.lifebridgehealth.org ↗
- Named one of "the best physicians in America" by US News & World Report
The Washington Post Magazine, and Best Doctors
2011verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.lifebridgehealth.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
- Professor of Medicine
Johns Hopkins University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →inovaheart.org ↗ - Director
Interventional Cardiology and Cardiovascular Medicine Research, Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →inovanewsroom.org ↗
Media & interviews
press, podcasts and appearances- citybiz Interview: Paul Gurbel
M.D. – Sinai Hospital of Baltimore (video interview)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology